Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

JANXJANX
Showing 8 of 21 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in JANUX THERAPEUTICS INC

CITADEL ADVISORS LLC holds 1.2M shares of JANX (JANUX THERAPEUTICS INC), worth $18.4M as of 2026-Q2. The position was increased (+240.9% shares). JANX represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$18.4M

Current Shares

1.2M

Total Value Change

-$27.4M

Total Shares Change

+190,969

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.2M
+240.9%
$18.4M0.0%$15.36
46
2026-Q1
Decreased
352,177
-68.1%
$4.9M0.0%$13.44
0
2025-Q4
Increased
1.1M
+37.5%
$15.2M0.0%$13.83
37
2025-Q3
Decreased
802,784
-34.8%
$19.6M0.0%$23.70
0
2025-Q2
Increased
1.2M
+74.2%
$28.4M0.0%$23.15
43
2025-Q1
Decreased
706,664
-48.1%
$19.1M0.0%$29.10
0
2024-Q4
Increased
1.4M
+34.8%
$72.9M0.0%$52.50
38
2024-Q3
Decreased
1M
-35.1%
$45.9M0.0%$46.25
0

Other major holders of JANX: RA CAPITAL MANAGEMENT, L.P., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used